propionic acid and paclitaxel

propionic acid has been researched along with paclitaxel in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, Y; Duan, XC; Feng, ZH; Li, H; Li, ZY; Liao, A; Peng, LY; Wang, GX; Wang, JR; Xu, MQ; Yao, X; Zhang, SQ; Zhang, X	1

Other Studies

1 other study(ies) available for propionic acid and paclitaxel

Article	Year
The synergistic antitumor activity of 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) and anti-PD-L1 antibody inducing immunogenic cell death. Drug delivery, 2021, Volume: 28, Issue:1 Topics: Albumins; Animals; Antineoplastic Agents; B7-H1 Antigen; Calreticulin; Cell Line, Tumor; Female; HMGB1 Protein; Humans; Immunogenic Cell Death; Inflammation Mediators; Mice; Mice, Inbred BALB C; Nanoparticles; Paclitaxel; Propionates; Up-Regulation; Xenograft Model Antitumor Assays	2021

Article

Year

The synergistic antitumor activity of 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) and anti-PD-L1 antibody inducing immunogenic cell death.

Drug delivery, 2021, Volume: 28, Issue:1

Topics: Albumins; Animals; Antineoplastic Agents; B7-H1 Antigen; Calreticulin; Cell Line, Tumor; Female; HMGB1 Protein; Humans; Immunogenic Cell Death; Inflammation Mediators; Mice; Mice, Inbred BALB C; Nanoparticles; Paclitaxel; Propionates; Up-Regulation; Xenograft Model Antitumor Assays

2021